Trainee Poster Session
In November of 2008, graduate students, postdoctoral fellows, residents, and staff from our muscle group came together and presented their work in our first annual trainee poster session. The event was held in the lobby of the Biomedical Research Tower on the campus of Ohio State and was accompanied with a reception. Over 30 posters were presented representing a diversity of muscle related topics, whose titles are shown below.
Characterization and in vitro expansion of muscle progenitor
cells for use in cell based therapies for muscular dystrophy
Characterization of mdx and mdx5Cv mouse models for application
in the study of Duchenne muscular dystrophy treatment strategies
Cyclic compressive loading facilitates recovery following eccentric
exercise
NF-kb – YY1 – mIR29 regulatory circuitry in skeletal
myogenesis and rhabdomyosarcoma
Single fiber isolation and pax7 immunofluoresence
Understanding the role of the cell junction protein claudin-5
in cardiomyopathy and heart failure
NF-kB functions as an inhibitor of post-natal muscle development
Genotype analysis predicts dilated cardiomyopathy in Beckers
muscular dystrophy
FSHD candidate gene DUX4 causes in vivo myotoxicity
Evidence for the involvement of early insulin resistance in the
development of cachexia in mice bearing colon-26 tumors
Evidence for metabolic inflexibility during atrophy of cardiac
muscle in mice
Nitroxyl improves cardiac myocyte contraction independent of
L-type Calcium current
Effect of Calcium binding properties of TnC on the rate of skeletal
muscle tension redevelopment
Abnormal Calcium binding properties of the thin filaments caused
by the cardiomyopathy mutation TnI R192H can be corrected through TnC
mutagnesis
Neuronal nitric oxide synthase (NOS1) knockout mice exhibit a
blunted force frequency response
Reversal of the cardiac dysfunction in neuronal nitric oxide
synthase knockout myocytes by the nitric oxide donor SNAP
Generation of a new mouse model to help determine the therapeutic
time-point for SMN replacement therapies: An update
Development and characterization of a transgenic mutant sod1
zebrafish model of ALS
CASK localizes to multiple subcellular fractions and plays an
important function in skeletal muscle integrity
O-fucosylation of muscle agrin determines its ability to cluster
acetylcholine receptors
Myostatin inhibition by follastin gene therapy improves dystrophic
symptoms in dy/dy mice
Transgenic overexpression of CT GalNac transferase (Galgt2) in
skeletal muscle inhibits muscular dystrophy in a mouse model of limb-girdle
muscular dystrophy 2D
IGF-1 rescues motor neuron toxicity in an in vitro stem cell-based
model of ALS
Dynamic relaxation primarily determined by myofilament properties
A gene therapy strategy utilizing follastatin combined with micro-dystrophin
dramatically improves force generation in mdx mice
Mechanical properties of atrial muscle preparations
Functional and molecular changes during development of compensatory
hypertrophy
Eccentric contraction in mdx mice trabeculae
Transcriptional programming of embryonic and adult stem cells
Impact of hydroxyl radicals on calcium handling and myofilament
sensitivity in isolated myocardium
Experimental targeted gene therapy for quadriceps muscle weakness
for sporadic inclusion body myositis (sIBM) with implications for other
neuromuscular disorders
Regulation of the splicing mechanism of MDM2 in response to DNA
damage using a splicing competent minigene system
